TY - JOUR
T1 - COVID-19 pandemic
T2 - Practical considerations on the organization of an allergy clinic-An EAACI/ARIA Position Paper
AU - European Academy of Allergy & Clinical Immunology (EAACI) Task Force: Non-specific Lipid Transfer Protein Allergy Across Europe
AU - Pfaar, Oliver
AU - Klimek, Ludger
AU - Jutel, Marek
AU - Akdis, Cezmi A
AU - Bousquet, Jean
AU - Breiteneder, Heimo
AU - Chinthrajah, Sharon
AU - Diamant, Zuzana
AU - Eiwegger, Thomas
AU - Fokkens, Wytske J
AU - Fritsch, Hans-Walter
AU - Nadeau, Kari C
AU - O'Hehir, Robyn E
AU - O'Mahony, Liam
AU - Rief, Winfried
AU - Sampath, Vanitha
AU - Schedlowski, Manfred
AU - Torres, María José
AU - Traidl-Hoffmann, Claudia
AU - Wang, De Yun
AU - Zhang, Luo
AU - Bonini, Matteo
AU - Brehler, Randolf
AU - Brough, Helen Annaruth
AU - Chivato, Tomás
AU - Del Giacco, Stefano R
AU - Dramburg, Stephanie
AU - Gawlik, Radoslaw
AU - Gelincik, Aslı
AU - Hoffmann-Sommergruber, Karin
AU - Hox, Valerie
AU - Knol, Edward F
AU - Lauerma, Antti
AU - Matricardi, Paolo M
AU - Mortz, Charlotte G
AU - Ollert, Markus
AU - Palomares, Oscar
AU - Riggioni, Carmen
AU - Schwarze, Jürgen
AU - Skypala, Isabel
AU - Untersmayr, Eva
AU - Walusiak-Skorupa, Jolanta
AU - Ansotegui, Ignacio J
AU - Bachert, Claus
AU - Bedbrook, Anna
AU - Bosnic-Anticevich, Sinthia
AU - Brussino, Luisa
AU - Canonica, Giorgio Walter
AU - Cardona, Victoria
AU - Carreiro-Martins, Pedro
N1 - Publisher Copyright: © 2020 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2021/3
Y1 - 2021/3
N2 - BACKGROUND: The coronavirus disease 2019 (COVID-19) has evolved into a pandemic infectious disease transmitted by the severe acute respiratory syndrome coronavirus (SARS-CoV-2). Allergists and other healthcare providers (HCPs) in the field of allergies and associated airway diseases are on the front line, taking care of patients potentially infected with SARS-CoV-2. Hence, strategies and practices to minimize risks of infection for both HCPs and treated patients have to be developed and followed by allergy clinics.METHOD: The scientific information on COVID-19 was analysed by a literature search in MEDLINE, PubMed, the National and International Guidelines from the European Academy of Allergy and Clinical Immunology (EAACI), the Cochrane Library, and the internet.RESULTS: Based on the diagnostic and treatment standards developed by EAACI, on international information regarding COVID-19, on guidelines of the World Health Organization (WHO) and other international organizations, and on previous experience, a panel of experts including clinicians, psychologists, IT experts, and basic scientists along with EAACI and the "Allergic Rhinitis and its Impact on Asthma (ARIA)" initiative have developed recommendations for the optimal management of allergy clinics during the current COVID-19 pandemic. These recommendations are grouped into nine sections on different relevant aspects for the care of patients with allergies.CONCLUSIONS: This international Position Paper provides recommendations on operational plans and procedures to maintain high standards in the daily clinical care of allergic patients while ensuring the necessary safety measures in the current COVID-19 pandemic.
AB - BACKGROUND: The coronavirus disease 2019 (COVID-19) has evolved into a pandemic infectious disease transmitted by the severe acute respiratory syndrome coronavirus (SARS-CoV-2). Allergists and other healthcare providers (HCPs) in the field of allergies and associated airway diseases are on the front line, taking care of patients potentially infected with SARS-CoV-2. Hence, strategies and practices to minimize risks of infection for both HCPs and treated patients have to be developed and followed by allergy clinics.METHOD: The scientific information on COVID-19 was analysed by a literature search in MEDLINE, PubMed, the National and International Guidelines from the European Academy of Allergy and Clinical Immunology (EAACI), the Cochrane Library, and the internet.RESULTS: Based on the diagnostic and treatment standards developed by EAACI, on international information regarding COVID-19, on guidelines of the World Health Organization (WHO) and other international organizations, and on previous experience, a panel of experts including clinicians, psychologists, IT experts, and basic scientists along with EAACI and the "Allergic Rhinitis and its Impact on Asthma (ARIA)" initiative have developed recommendations for the optimal management of allergy clinics during the current COVID-19 pandemic. These recommendations are grouped into nine sections on different relevant aspects for the care of patients with allergies.CONCLUSIONS: This international Position Paper provides recommendations on operational plans and procedures to maintain high standards in the daily clinical care of allergic patients while ensuring the necessary safety measures in the current COVID-19 pandemic.
KW - COVID-19
KW - Position Paper
KW - SARS-CoV-2
KW - allergen immunotherapy
KW - allergy clinic
KW - anaphylaxis
KW - asthma
KW - clinical trials
KW - psychological impact
UR - http://www.scopus.com/inward/record.url?scp=85094559421&partnerID=8YFLogxK
U2 - https://doi.org/10.1111/all.14453
DO - https://doi.org/10.1111/all.14453
M3 - Article
C2 - 32531110
SN - 0105-4538
VL - 76
SP - 648
EP - 676
JO - Allergy
JF - Allergy
IS - 3
ER -